Literature DB >> 22149764

Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study.

Ronald A Brooks1, Raphael J Landovitz, Rachel L Kaplan, Eli Lieber, Sung-Jae Lee, Thomas W Barkley.   

Abstract

The objective of this mixed methods study was to examine current sexual risk behaviors, acceptability and potential adoption of pre-exposure prophylaxis (PrEP) for HIV prevention, and sexual behavior intentions with PrEP adoption among HIV-negative gay and bisexual men (GBM) in HIV serodiscordant relationships. A multiracial/ethnic sample of 25 HIV-negative GBM in serodiscordant relationships completed a qualitative interview and a brief interviewer-administered survey. A modified grounded theory approach was used to identify key themes relating to acceptability and future adoption of PrEP. Participants reported engaging in sexual risk behaviors that place them at risk for HIV infection. Participants also reported a high level of acceptability for PrEP and willingness to adopt PrEP for HIV prevention. Qualitative themes explaining future PrEP adoption included: (1) the opportunity to engage in sex using a noncondom HIV prevention method, (2) protection from HIV infection, and (3) less anxiety when engaging in sex with an HIV-positive partner. Associated with the future adoption of PrEP, a majority (64%) of participants indicated the likelihood for an increase in sexual risk behaviors and a majority (60%) of participants also indicated the likelihood for a decrease or abandonment of condom use, both of which are in contrast to the findings from the large iPrEx study. These findings suggest that the use of PrEP by HIV-negative GBM in serodiscordant relationships carries with it the potential for risk compensation. The findings suggest that PrEP only be offered as part of a comprehensive HIV prevention strategy that includes ongoing risk reduction counseling in the delivery of PrEP to help moderate risk compensation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22149764      PMCID: PMC3266517          DOI: 10.1089/apc.2011.0283

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  18 in total

1.  Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004.

Authors:  Scott E Kellerman; Angela B Hutchinson; Elin B Begley; Brian C Boyett; Hollie A Clark; Patrick Sullivan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

Review 2.  Pre-exposure prophylaxis for HIV infection: what if it works?

Authors:  Lynn A Paxton; Tony Hope; Harold W Jaffe
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

3.  Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

Authors:  K K Van Rompay; M B McChesney; N L Aguirre; K A Schmidt; N Bischofberger; M L Marthas
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

4.  Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation.

Authors:  Jeffrey T Parsons; Eric W Schrimshaw; Richard J Wolitski; Perry N Halkitis; David W Purcell; Colleen C Hoff; Cynthia A Gómez
Journal:  AIDS       Date:  2005-04       Impact factor: 4.177

5.  Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.

Authors:  Dawn K Smith; Lisa A Grohskopf; Roberta J Black; Judith D Auerbach; Fulvia Veronese; Kimberly A Struble; Laura Cheever; Michael Johnson; Lynn A Paxton; Ida M Onorato; Alan E Greenberg
Journal:  MMWR Recomm Rep       Date:  2005-01-21

6.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

7.  Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men.

Authors:  Albert Y Liu; Pravina V Kittredge; Eric Vittinghoff; H Fisher Raymond; Katherine Ahrens; Tim Matheson; Jennifer Hecht; Jeffrey D Klausner; Susan P Buchbinder
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

8.  Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback.

Authors:  N Nodin; A Carballo-Diéguez; A M Ventuneac; I C Balan; R Remien
Journal:  AIDS Care       Date:  2008-01

9.  Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.

Authors:  Kamal Desai; Stephanie L Sansom; Marta L Ackers; Scott R Stewart; H Irene Hall; Dale J Hu; Rachel Sanders; Carol R Scotton; Sada Soorapanth; Marie-Claude Boily; Geoffrey P Garnett; Peter D McElroy
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

10.  Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

Authors:  J Gerardo García-Lerma; Ron A Otten; Shoukat H Qari; Eddie Jackson; Mian-Er Cong; Silvina Masciotra; Wei Luo; Caryn Kim; Debra R Adams; Michael Monsour; Jonathan Lipscomb; Jeffrey A Johnson; David Delinsky; Raymond F Schinazi; Robert Janssen; Thomas M Folks; Walid Heneine
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  93 in total

Review 1.  Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.

Authors:  Kellie Freeborn; Carmen J Portillo
Journal:  J Clin Nurs       Date:  2018-09       Impact factor: 3.036

2.  Will risk compensation accompany pre-exposure prophylaxis for HIV?

Authors:  Jill Blumenthal; Richard H Haubrich
Journal:  Virtual Mentor       Date:  2014-11-01

3.  Examining the role of serostatus disclosure on unprotected sex among people living with HIV.

Authors:  Sarahmona Przybyla; Carol Golin; Laura Widman; Catherine Grodensky; Jo Anne Earp; Chirayath Suchindran
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

4.  Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.

Authors:  Jaclyn M White; Matthew J Mimiaga; Douglas S Krakower; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2012-06-13       Impact factor: 5.078

5.  Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.

Authors:  Michael E Newcomb; Kevin Moran; Brian A Feinstein; Emily Forscher; Brian Mustanski
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

6.  Perceived Advantages and Disadvantages of Using Pre-Exposure Prophylaxis (PrEP) among Sexually Active Black Women: An Exploratory Study.

Authors:  Keosha T Bond; Alana J Gunn
Journal:  J Black Sex Relatsh       Date:  2016

Review 7.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

8.  Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.

Authors:  Jason Kessler; Julie E Myers; Kimberly A Nucifora; Nana Mensah; Christopher Toohey; Amin Khademi; Blayne Cutler; Scott Braithwaite
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

9.  Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study.

Authors:  Rafael E Pérez-Figueroa; Farzana Kapadia; Staci C Barton; Jessica A Eddy; Perry N Halkitis
Journal:  AIDS Educ Prev       Date:  2015-04

10.  Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.

Authors:  Hailey J Gilmore; Albert Liu; Kimberly Ann Koester; K Rivet Amico; Vanessa McMahan; Pedro Goicochea; Lorena Vargas; David Lubensky; Susan Buchbinder; Robert Grant
Journal:  AIDS Patient Care STDS       Date:  2013-10       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.